tirzepatide shortage news today The Is Over: Here's What You Need to Know FDA makes end of Zepbound,

The downsides for postpartum use specifically are the limited breast milk data and a side effect profile that some women find more intense during the initial titration period

Although a trend toward reduced HCC risk was observed, this failed to achieve statistical significance in the overall analysis (IRR: 0.82, 95%CI: 0.61-1.11, P = 0.189), possibly reflecting insufficient follow-up duration to capture the full impact on hepatocarcinogenesis

Common gastrointestinal side effects include, according to the Saxenda Summary of Product Characteristics (SmPC): Nausea (reported in approximately 40% of patients) Diarrhoea (affecting around 20% of users) Constipation (occurring in approximately 20% of patients) Vomiting (experienced by roughly 16% of users) Dyspepsia (indigestion) Abdominal pain or discomfort Gastro-oesophageal reflux disease (GORD) These effects are typically most pronounced during the initial weeks of treatment and often diminish as the body adjusts to the medication

But not always

These days, I consider myself a science-minded beauty journalist unafraid of interrogating iffy claims put forward by products, brands, and personalities